Hong Kong Stock Exchange Issues New Guidance for Biotech Listings

Published date25 May 2020
Subject MatterListing Standards,Biotechnology,Corporate Governance,Hong Kong
AuthorCathy Yeung,Michael Sullivan,Terris Tang
Law FirmLatham & Watkins LLP

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT